RCCA oncologists outline pioneering approach to clinical trials for cancer patients
Share on facebook Share on twitter Share on linkedin Share on email Share on print Enabling people with cancer to participate in clinical trials without
groundbreaking clinical trials
in new jersey, connecticut, MASSACHUSETTS, and maryland
RCCA is dedicated to the continual improvement of cancer care — from prevention to treatment through recovery and beyond. Which is why we participate in more than 300 advanced clinical trials.
Groundbreaking Clinical Trials
in New Jersey, Connecticut and Maryland
RCCA is dedicated to the continual improvement of cancer care — from prevention to treatment through recovery and beyond. Which is why we participate in more than 300 advanced clinical trials.
We’re here for you. Call us at 844-346-7222 or
Search clinical trials
What are clinical trials?
Clinical trials are carefully designed and managed scientific studies. These trials test new medical therapies (medications, devices, etc.) and their effectiveness in the prevention, detection, diagnosis and cure of diseases. Clinical trials are how all medical therapies, devices and techniques are evaluated for human use. Without clinical trials for breast, colon, lung, prostate, and other cancers, new drugs and treatments for cancer would not be investigated, get approved or be available to treat and benefit patients.
Why enroll in a clinical trial?
Cancer treatments are constantly evolving and advancing, and new methods and medications are always in development. Phase I, Phase II, and Phase III clinical trials provide cancer patients and their families with real hope for improvement, a higher quality of life, and, in many cases, a longer life. Other reasons to consider enrolling in a clinical trial include:
- Safety – Clinical trials would not occur if not for strict regulations in place to help ensure patient safety. An institutional review board, along with scientific experts, monitor trial protocols.
- Informed consent – During this process, you can learn all about the trial before deciding if you wish to take part. You will know the trial’s purpose along with possible risks and benefits. Informed consent is critical to ensuring patient safety.
- Affordability – The cost of care associated with the clinical trial is covered by the company sponsoring the clinical trial.
RCCA always puts your health and safety first
Clinical trials have given thousands of RCCA patients new hope. You can be confident that RCCA oncologists will prioritize your well-being and safety above all else. We work with local physicians to collect your complete medical history and form a treatment plan or protocol. The counseling you will receive as part of the informed consent process will contain information on the purpose of the trial, the drugs involved, medical tests to be performed, possible side effects, and some statistics about other people in the clinical trial.
At RCCA, we have the knowledge and expertise to assure the highest quality of care. And with more than 25 locations in New Jersey, Connecticut and Maryland, we strive to make innovative treatments and community-based, personalized care as accessible as possible. To find out if a clinical trial is right for you, or to schedule an appointment, call (201) 518-3587.
we are here for you
For more information, or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Treatments for Hematologic Cancers (Blood Cancers)
Hematologic cancer, or blood cancer, is one of the most common diagnoses treated at Regional Cancer Care Associates. Blood cancer refers to types like leukemia
Is a Clinical Trial is Right for You? How to Decide
Deciding whether to participate in a clinical trial can be difficult, even if your oncologist recommends it. Ultimately, it’s your decision, and that can feel
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.